MedPath

change in Muscle volume In patients with LivEr cirrhosis: prospective cohort Study

Not Applicable
Conditions
iver cirrhosis
Registration Number
JPRN-UMIN000023256
Lead Sponsor
Hyogo College of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients being treated with intravenous albumin preparation 2.Patients being treated with fresh frozen plasma formulation 3.Patients with stage II or more advanced HCC 4.Patients with uncontrollable HCC 5.Patients with total bilirubin >3.0 mg/dl 6.Patients with hepatic encephalopathy (hepatic coma: grade III or more) 7.Patients with congenital branched-chain amino acid related metabolic disorders 8.Patients with malignancies other than HCC 9.Patients ineligible for study as determined by research investigator or research doctor

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Annual changes in muscle mass volume
Secondary Outcome Measures
NameTimeMethod
Overall survival Time to liver disease-related event
© Copyright 2025. All Rights Reserved by MedPath